TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.

Shannon N Westin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.